Status:
ACTIVE_NOT_RECRUITING
Remote MS Care in Antwerp
Lead Sponsor:
University Hospital, Antwerp
Collaborating Sponsors:
Janssen-Cilag div. of Johnson&Johnson SE
icometrix
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Current clinical follow-up of multiple sclerosis (MS) patients suffers from some challenges, as many patients indicate they want to take up a more active role in the decision-making process. However, ...
Eligibility Criteria
Inclusion
- A diagnosis of multiple sclerosis (MS, including relapsing-remitting MS, primary-progressive MS and secondary-progressive MS, in accordance with 2017 revisions of McDonald criteria and disease course definitions of Lublin,
- Age 18 or above,
- Able to give informed consent (written or verbal with witness signing on behalf of patient) and to adhere to study procedures,
- Dutch/Flemish speaking.
Exclusion
- Unable or unwilling to use the smartphone-based icompanion app.
- Prior use of the icompanion app.
Key Trial Info
Start Date :
May 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06179758
Start Date
May 23 2024
End Date
March 1 2026
Last Update
June 19 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Antwerp
Edegem, Antwerpen, Belgium, 2650
2
ZAS Middelheim
Antwerp, Belgium, 2020
3
AZ Klina
Brasschaat, Belgium, 2930